This website uses cookies to enhance the user experience.
ONCOINVENT ASA

ONCOINVENT ASA995 764 458

Research
Public limited company
Gullhaugveien 7 0484 OSLO, Norge

ONCOINVENT ASA

Home - Oncoinvent
Committed to developing new innovative radiopharmaceutical products for better treatment options for cancer patients Watch company presentation, or download (.pdf) Latest news and press releases ALL202420232022202120202019201820172016 15. May. 2024 Oncoinvent to Present at Cantor Fitzgerald Frontiers in Radiopharma Virtual Summit 2. Apr. 2024 Oncoinvent Announces Changes to its Board of Directors and Formation of Scientific ... Read more

Keywords

researchdevelopment worknatural sciencesengineeringtechnologymedicineagricultureinterdisciplinary research

Links

Organization

CEO
Chairman of the board
Years since formation
15 years
since Aug 11, 2010
Type
Public limited company
VAT registered
Yes
Number of employees
33

Ownership

Number of shares and share classes
92,243,343
1 share class
Total number of shareholders
613
188 companies, 425 persons

Financials

Total operating income 2023
5,790,000
NOK
Annual total result 2023
-143,621,000
NOK
Total equity 2023
54,931,000
NOK
Last update: May 14, 2025

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Board Member-
Chairman-
Board Member-
Board Member-
Board Member-
Board Member-
Observer-

Others

NameRoleShares
E
ERNST & YOUNG AS
Auditor-
Last update: Sep 5, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
NO0010779341
10,417,151
11.29 %
H
HADEAN CAPITAL I AS
NO0010779341
9,299,361
10.08 %
NO0010779341
9,143,749
9.91 %
S
SCIENCONS AS
NO0010779341
4,917,223
5.33 %
C
CANICA AS
NO0010779341
3,936,216
4.27 %
NO0010779341
3,720,411
4.03 %
M
MP PENSJON PK
NO0010779341
3,036,706
3.29 %
S
SBAKKEJORD AS
NO0010779341
2,750,000
2.98 %
O
OM HOLDING AS
NO0010779341
2,634,000
2.86 %
NO0010779341
2,388,758
2.59 %
H
HELENE SUNDT AS
NO0010779341
2,148,564
2.33 %
M
MYRLID AS
NO0010779341
2,000,000
2.17 %
S
STAVANGER FORVALTNING AS
NO0010779341
1,995,593
2.16 %
L
LUCELLUM AS
NO0010779341
1,160,000
1.26 %
J
JANDERSEN KAPITAL AS
NO0010779341
1,011,440
1.1 %
H
HILLEVÅGEN HOLDING AS
NO0010779341
1,007,692
1.09 %
N
NORDA ASA
NO0010779341
957,692
1.04 %
H
HARTVIG WENNBERG AS
NO0010779341
845,865
0.92 %
F
FINNVIK EIENDOM AS
NO0010779341
836,720
0.91 %
A
ALPINE CAPITAL AS
NO0010779341
800,000
0.87 %
M
MUST INVEST AS
NO0010779341
786,230
0.85 %
V
VICAMA AS
NO0010779341
739,560
0.8 %
B
BLAAHAUGEN AS
NO0010779341
732,500
0.79 %
S
SUNDT AS
NO0010779341
711,643
0.77 %
S
SKOG INVEST AS
NO0010779341
710,385
0.77 %
F
FARVATN VENTURE AS
NO0010779341
680,768
0.74 %
M
MUTUS AS
NO0010779341
673,462
0.73 %
NO0010779341
670,000
0.73 %
NO0010779341
658,850
0.71 %
NO0010779341
651,110
0.71 %
N
Nordisk Trading AS
NO0010779341
581,000
0.63 %
M
MYNA AS
NO0010779341
557,200
0.6 %
T
TIGERSTADEN AS
NO0010779341
529,483
0.57 %
A
ARVO INVEST AS
NO0010779341
493,340
0.53 %
B
BENTAX AS
NO0010779341
450,000
0.49 %
M
MALMAG CAPITAL AS
NO0010779341
435,385
0.47 %
S
Syntax AS
NO0010779341
400,000
0.43 %
NO0010779341
363,631
0.39 %
C
CATILINA INVEST AS
NO0010779341
318,300
0.35 %
P
PETROSERVICE AS
NO0010779341
310,000
0.34 %
O
OPTIMUSPISTOR AS
NO0010779341
308,872
0.33 %
NO0010779341
308,800
0.33 %
NO0010779341
302,600
0.33 %
L
LBM INVEST AS
NO0010779341
302,500
0.33 %
NO0010779341
298,250
0.32 %
G
GEC HOLDING AS
NO0010779341
295,000
0.32 %
L
LANGE INVESTERINGER AS
NO0010779341
290,500
0.31 %
S
SPARLI AS
NO0010779341
290,000
0.31 %
C
CGS HOLDING AS
NO0010779341
276,915
0.3 %
R
RO INVEST AS
NO0010779341
271,863
0.29 %
NO0010779341
261,250
0.28 %
T
TEAKAY INVEST AS
NO0010779341
247,104
0.27 %
A
ALPHABET AS
NO0010779341
245,000
0.27 %
S
SCORPIUS AS
NO0010779341
240,000
0.26 %
M
MANZANA AS
NO0010779341
230,000
0.25 %
I
INVEN2 AS
NO0010779341
210,261
0.23 %
P
PROGRESS TJENESTER AS
NO0010779341
210,110
0.23 %
N
NORDNET LIVSFORSIKRING AS
NO0010779341
209,591
0.23 %
W
WATRIUM AS
NO0010779341
206,923
0.22 %
NO0010779341
200,000
0.22 %
M
MH CAPITAL AS
NO0010779341
190,000
0.21 %
P
PIV INVEST AS
NO0010779341
185,501
0.2 %
J
JAG HOLDING AS
NO0010779341
185,000
0.2 %
N
NEMETH FINANS AS
NO0010779341
176,551
0.19 %
NO0010779341
171,000
0.19 %
B
BIRK VENTURE AS
NO0010779341
170,000
0.18 %
NO0010779341
166,000
0.18 %
H
HERBRANDSEN INVEST AS
NO0010779341
165,000
0.18 %
E
EURO HAGE OG ANLEGG AS
NO0010779341
164,766
0.18 %
P
PECUNIA FORVALTNING AS
NO0010779341
160,000
0.17 %
NO0010779341
157,000
0.17 %
H
HILS AS
NO0010779341
156,804
0.17 %
B
BAHIA AS
NO0010779341
150,000
0.16 %
G
GUTTIS AS
NO0010779341
150,000
0.16 %
A
ABAKUS INVEST AS
NO0010779341
150,000
0.16 %
B
BYENS MARKER INVEST AS
NO0010779341
146,301
0.16 %
NO0010779341
145,000
0.16 %
K
KRISTIAN FALNES AS
NO0010779341
140,000
0.15 %
A
AVIDUS AS
NO0010779341
140,000
0.15 %
NO0010779341
132,148
0.14 %
NO0010779341
127,879
0.14 %
NO0010779341
120,055
0.13 %
H
HACAPAR AS
NO0010779341
120,000
0.13 %
NO0010779341
120,000
0.13 %
W
WEATEA AS
NO0010779341
120,000
0.13 %
B
BAKERIKONSULTING AS
NO0010779341
100,000
0.11 %
NO0010779341
100,000
0.11 %
R
RH INDUSTRI AS
NO0010779341
100,000
0.11 %
D
DECISION LAB AS
NO0010779341
100,000
0.11 %
T
TROLA AS
NO0010779341
100,000
0.11 %
B
BASEN KAPITAL AS
NO0010779341
96,488
0.1 %
NO0010779341
95,300
0.1 %
NO0010779341
90,000
0.1 %
NO0010779341
89,290
0.1 %
K
KAPITAL INVEST AS
NO0010779341
87,500
0.09 %
P
PEGUS AS
NO0010779341
87,300
0.09 %
E
EVESTOR AS
NO0010779341
86,350
0.09 %
W
WORKPARTNER AS
NO0010779341
85,000
0.09 %
NO0010779341
80,000
0.09 %
G
GC RIEBER FORTUNA AS
NO0010779341
75,000
0.08 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year202320222021
Total operating income
5,790,000
6,282,500
11,083,018
Annual Total Result
-143,621,000
-103,756,765
-80,288,555
Total assets
98,734,000
222,244,881
317,620,406
Total liabilities
43,803,000
26,573,144
18,439,580
Total equity
54,931,000
195,671,737
299,180,826

P&L

Year202320222021
Total operating income
5,790,000
6,282,500
11,083,018
Total operating costs
153,215,000
114,370,066
91,925,009
Operating result
-147,425,000
-108,087,566
-80,841,991
Financial income/costs
3,804,000
4,330,801
553,436
Profit before tax
-143,621,000
-103,756,765
-80,288,555
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-143,621,000
-103,756,765
-80,288,555

Balance overview

Year202320222021
Total fixed assets
40,810,000
9,532,261
10,335,350
Total current assets
57,924,000
212,712,620
307,285,056
Total assets
98,734,000
222,244,881
317,620,406
Short term debt
35,456,000
26,573,144
18,439,580
Long term debt
8,347,000
0
0
Total liabilities
43,803,000
26,573,144
18,439,580
Contributed capital
551,491,000
539,587,150
539,339,469
Retained earnings
-496,560,000
-343,915,413
-240,158,643
Total equity
54,931,000
195,671,737
299,180,826
Total equity and liabilities
98,734,000
222,244,881
317,620,406

Classification

Category
Type of organization
Public limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.19
Industrial group
Other research and experimental development on natural sciences and engineering
72.190
Industrial group
Other research and experimental development on natural sciences and engineering